Mitos Pharmaceuticals, Inc.
Records under this name other than patents Mitos Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Mitos Pharmaceuticals, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,563,581 | Nitroxides for Use in Treating Predisposed or at Risk Patients Formerly held In force · High confidence | In force | High confidence | |
| US 7,625,928 | Nitroxide Radioprotector Formulations and Methods of Use Formerly held Term ended Term ended Sep 14, 2026 · High confidence | Term ended | Term ended Sep 14, 2026 | High confidence |
| US 10,245,256 | Nitroxides for Use in Treating or Preventing Diabetes and Obesity Formerly held Term ended Term ended Jun 4, 2026 · High confidence | Term ended | Term ended Jun 4, 2026 | High confidence |
| US 9,101,619 | Nitroxides for Use in Treating or Preventing Diabetes and Obesity Formerly held Term ended Term ended Feb 2, 2026 · High confidence | Term ended | Term ended Feb 2, 2026 | High confidence |
| US 9,522,143 | Nitroxides for Use in Treating or Preventing Diabetes and Obesity Formerly held Term ended Ended no later than Feb 2, 2026 · Medium confidence | Term ended | Ended no later than Feb 2, 2026 | Medium confidence |
| US 9,522,144 | Nitroxides for Use in Treating or Preventing Diabetes and Obesity Formerly held Term ended Term ended Feb 2, 2026 · High confidence | Term ended | Term ended Feb 2, 2026 | High confidence |